Published in Clinical Trials Week, November 14th, 2005
Scientists in the United States conducted a clinical trial to "identify a treatment-responsive population for botulinum toxin type A (BoNTA) and to evaluate the safety and efficacy of three different doses of BoNTA as prophylactic treatment" of CDH.
"A randomized, double-blind, placebo-controlled study of BoNTA in patients with CDH was conducted from July 6, 2001, through November 7, 2003, at 28 North American study centers," explained S.D. Silberstein and coauthors working at Thomas Jefferson University Hospital. "Eligible patients were...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.